TY - JOUR
T1 - Regulatory sanctions for ethically relevant GCP violations
AU - Bernabe, Rosemarie de la Cruz
AU - van Thiel, Ghislaine J. M. W.
AU - Breekveldt, Nancy S.
AU - Gispen, Christine C.
AU - van Delden, Johannes J. M.
N1 - Funding Information:
This project was funded by the Dutch Medicines Evaluation Board . The views expressed by the authors are their personal views and must not be understood or quoted as being made on behalf of or reflecting the position of the Dutch Medicines Evaluation Board.
Publisher Copyright:
© 2019 The Authors
PY - 2019/11
Y1 - 2019/11
N2 - Although EU inspectors and clinical assessors are mandated to identify and act upon ethical issues, regulators lack guidance on how this can be done. Hence, we propose a four-step regulatory approach on ethically relevant GCP violation findings. The first step is identification of the ethical issue. Next is analysis [i.e., identifying the gravity (intensity or severity) and the magnitude (amount and duration) of the ethics violation as well as the responsible person(s) or entity or entities]. The third step is evaluation, (i.e., the process of deliberating to determine the significance of the ethics violation, with the intention of identifying the most reasonable sanction and/or corrective or reparative action). Last is decision-making or the process of choosing and implementing a regulatory course of action.
AB - Although EU inspectors and clinical assessors are mandated to identify and act upon ethical issues, regulators lack guidance on how this can be done. Hence, we propose a four-step regulatory approach on ethically relevant GCP violation findings. The first step is identification of the ethical issue. Next is analysis [i.e., identifying the gravity (intensity or severity) and the magnitude (amount and duration) of the ethics violation as well as the responsible person(s) or entity or entities]. The third step is evaluation, (i.e., the process of deliberating to determine the significance of the ethics violation, with the intention of identifying the most reasonable sanction and/or corrective or reparative action). Last is decision-making or the process of choosing and implementing a regulatory course of action.
UR - http://www.scopus.com/inward/record.url?scp=85069559150&partnerID=8YFLogxK
U2 - 10.1016/j.drudis.2019.07.001
DO - 10.1016/j.drudis.2019.07.001
M3 - Review article
C2 - 31288094
SN - 1359-6446
VL - 24
SP - 2116
EP - 2119
JO - Drug Discovery Today
JF - Drug Discovery Today
IS - 11
ER -